Production of high purity alveolar-like cells from iPSCs through depletion of uncommitted cells after AFE induction
- PMID: 28802115
- DOI: 10.1016/j.diff.2017.08.001
Production of high purity alveolar-like cells from iPSCs through depletion of uncommitted cells after AFE induction
Abstract
Protocols to differentiate induced pluripotent stem cells (iPSCs) into specialized cells are continually evolving. iPSCs can be differentiated to alveolar cells with protocols that focus on development, specifically by inducing differentiation into definitive endoderm (DE), anterior foregut endoderm (AFE) and then lung bud progenitor intermediaries. However, current protocols result in a relatively low yield of the desired alveolar cells. The aim of this study was to evaluate whether depleting uncommitted cells after AFE induction would have a beneficial effect on alveolar cell yield. iPSCs were differentiated on Matrigel-coated plates for 25days. At each stage, phenotype was assessed using flow cytometry, immunofluorescence and qRT-PCR. Additionally, samples were dissociated in trypsin following AFE induction to improve the purity of the cells for the subsequent lung differentiation phase. Finally, the efficacy of dissociating the samples was confirmed comparing the expression of markers indicative of pluripotency and apoptosis. The ability to differentiate iPSCs to DE was 96% and to AFE was 97% utilizing our current protocol. After depletion of uncommitted cells and 12 days in culture, the purity of lung bud progenitors was 99%. Finally, the percentage of alveolar types I and II at the end of differentiation was 74% as compared to 31% in control cultures that had not been depleted of uncommitted cells after AFE induction. In conclusion, depletion of uncommitted cells after AFE induction, improves terminal differentiation of alveolar cells from 31% to 74%.
Keywords: Alveolar cell; Anterior foregut endoderm; Differentiation; Flow cytometry; Induced pluripotent stem cell.
Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Generation of induced pluripotent stem cell-derived anterior foregut endoderms on integrin-binding short peptide-based synthetic substrates.Biomed Mater. 2025 Apr 9;20(3). doi: 10.1088/1748-605X/adc52b. Biomed Mater. 2025. PMID: 40132264
-
Keratinocyte growth factor and dexamethasone plus elevated cAMP levels synergistically support pluripotent stem cell differentiation into alveolar epithelial type II cells.Tissue Eng Part A. 2013 Apr;19(7-8):938-51. doi: 10.1089/ten.tea.2012.0066. Epub 2013 Jan 15. Tissue Eng Part A. 2013. PMID: 23176317
-
Improvement of Cell Survival During Human Pluripotent Stem Cell Definitive Endoderm Differentiation.Stem Cells Dev. 2015 Nov 1;24(21):2536-46. doi: 10.1089/scd.2015.0018. Epub 2015 Aug 3. Stem Cells Dev. 2015. PMID: 26132288 Free PMC article.
-
Induced pluripotent stem cells for treating cystic fibrosis: State of the science.Pediatr Pulmonol. 2018 Nov;53(S3):S12-S29. doi: 10.1002/ppul.24118. Epub 2018 Jul 30. Pediatr Pulmonol. 2018. PMID: 30062693 Review.
-
Embryonic and induced pluripotent stem cells for lung regeneration.Ann Am Thorac Soc. 2015 Mar;12 Suppl 1:S50-3. doi: 10.1513/AnnalsATS.201410-457MG. Ann Am Thorac Soc. 2015. PMID: 25830836 Review.
Cited by
-
Human induced pluripotent stem cells ameliorate hyperoxia-induced lung injury in a mouse model.Am J Transl Res. 2020 Jan 15;12(1):292-307. eCollection 2020. Am J Transl Res. 2020. PMID: 32051754 Free PMC article.
-
hPSC-derived lung organoids: Potential opportunities and challenges.Heliyon. 2023 Feb 4;9(2):e13498. doi: 10.1016/j.heliyon.2023.e13498. eCollection 2023 Feb. Heliyon. 2023. PMID: 36814627 Free PMC article. Review.
-
Hyperoxia-induced bronchopulmonary dysplasia: better models for better therapies.Dis Model Mech. 2021 Feb 23;14(2):dmm047753. doi: 10.1242/dmm.047753. Dis Model Mech. 2021. PMID: 33729989 Free PMC article. Review.
-
Rapid Generation of Pulmonary Organoids from Induced Pluripotent Stem Cells by Co-Culturing Endodermal and Mesodermal Progenitors for Pulmonary Disease Modelling.Biomedicines. 2023 May 18;11(5):1476. doi: 10.3390/biomedicines11051476. Biomedicines. 2023. PMID: 37239147 Free PMC article.
-
Viral pandemic preparedness: A pluripotent stem cell-based machine-learning platform for simulating SARS-CoV-2 infection to enable drug discovery and repurposing.Stem Cells Transl Med. 2021 Feb;10(2):239-250. doi: 10.1002/sctm.20-0181. Epub 2020 Sep 22. Stem Cells Transl Med. 2021. PMID: 32961040 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources